Abstract
The best known model to explain the observed radiosensit izing actions of oxygen or electron affinic drugs on hypoxic cells irradiated in vitro is that of “radical repair” (1–3). The model states that radiation-induced radicals produced in critical molecules (like DNA) undergo competitive reactions either with oxidizing species, such as oxygen or other electron affinic agents (e.g. misonidazole) leading to damage “fixation” followed by cell death (Figure 1), or with reducing species, such as non-protein thiols (NPSH) leading to damage “repair” (perhaps through hydrogen atom donation) followed by continued cell viability. Support for this model comes from pulse radiolysis techniques. For simple molecules the reactions of molecular oxygen with free radicals occur at essentially diffusion controlled rates, both for radical addition or electron transfer which occurs less frequently (4, 5). The ratio of the rate constant for radical fixation relative to that for repair is in the range of 200–1000; it is constant at about 200 for both poly-U in the presence of GSH and for transforming DNA in solution (6).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alper T, Howard-Flanders P: Role of oxygen in modifying the radiosensitivity of E. Coli B. Nature 178: 978–979, 1956.
Howard-Flanders P: Physical and chemical mechanisms in the injury of cells by ionizing radiations. Adv. Biol. Med. and Phys. 6: 553–603, 1958.
Howard-Flanders P, Moore D: The time interval after pulsed irradiation within which injury to bacteria can be modified by dissolved oxygen. Radiat. Res. 9: 442–437, 1958.
Adams GE: Molecular mechanisms of cellular radiosensitization and protection. In: Radiation Protection and Sensitization, Moroson HL, Quintilliani M (eds), London, Taylor and Frances, 1970, pp. 3–14.
Greenstock CL: Redox processes in radiation biology and cancer. Radiat. Res. 86: 196–211, 1981.
Schulte-Frohlinde D: Kinetics and mechanism of DNA strand breaks. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic, M (eds), New York, Academic Press, 1983, pp. 53–72.
Howard-Flanders P, Levin J, Theriot L: Reactions of DNA radicals with SH compounds in x-irradiated bacteriophage systems. Radiat. Res. 18: 593–606, 1963.
Johansen I, Howard-Flanders P: Macromolecular repair and free radical scavenging in the protection of bacteria against x-rays. Radiat. Res. 24: 184–200, 1965.
Held KD, Harrop HA, Michael BD: Reaction kinetics of SH-containing compounds and oxygen with irradiated transforming DNA. Radiat. Res. 91: 304, 1982.
Biaglow JE, Varnes ME, Clark EP, Epp ER: The role of thiols in cellular response to radiation and drugs. Radiat. Res. 95: 437–455, 1983.
Adams GE: Hypoxic cell sensitizers for radiotherapy. In: Cancer: A Comprehensive Treatise, Becker FF (ed), New York, Plenum, 1978, 6: 181–223.
Harris JW: Cellular thiols in radiation and drug response: Use of specific reagents. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic, M (eds), New York, Academic Press, 1983, pp. 255–274.
Chapman JD, Reuvers AP, Borsa J, Greenstock CL: Radio-protection and radiosensitization of mammalian cells growing in vitro. Radiat. Res. 56: 291–306, 1973.
Varnes ME, Biaglow JE, CJ Koch, EJ Hall: Depletion of nonprotein thiols of hypoxic cells by misonidazole and metronidazole. In: Radiation Sensitizers, Cancer Management, Vol. 5, Chapter 18, Brady L (ed), New York, Masson Publishing Co., 1980, pp. 121–126.
Biaglow JE, Varnes ME, Astor M, Hall EJ: Mechanism of misonidazole-linked cytotoxicity and altered radiation response: Role of cellular thiols. Brit. J. Radiol. 54: 1006–1008, 1981.
Bump EA, Yu NY, Brown JM: Radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione. Science 217: 544–545, 1982.
Koch CJ: Competition between radiation protectors and radiation sensitizers in mammalian cells. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 275–296.
Adams GE, Sheldon PW, Stratford IJ: Evaluation of novel radiation sensitizers in vitro and in vivo. Int. J. Radiat. Oncol. Biol. and Phys. 8: 419–421, 1982.
Griffith OW, Meister A: Potent and specific inhibition of glutathione synthesis of buthionine sulfoximine (S-n buty homocysteine sulfoximine). J. Biol. Chem. 254: 121–152, 1979.
Meister A: Glutathione metabolism and transport. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 121–152.
Malaise EP: Reduced oxygen enhancement of radiosensitivity of glutathione-deficient fibroblasts as demonstrated by their clonogenic survival. Radiat. Res. 95: 480–490, 1983.
Revesz L: Studies with glutathione-deficient human cells. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 237–245.
Bridges BA: Sensitization of organisms to radiation by sulfhydryl binding agents. Adv. Radiat. Biol. 3: 123–176, 1969.
Biaglow JE, Varnes ME, Epp ER, Clark EP: Cell redox thiyl radicals, Breccia A, Rogers M (eds), Italy, Edizione Scientifiche, 1986, in press.
Nygaard OF, Simic M: Radioprotectors and Anticarcinogens, New York, Academic Press, 1983.
Reed DJ: Regulation and function of glutathione in cells. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 153–168.
Meister A: On the cycles of glutathione metabolism and transport. Current Topics in Cell. Reg. 18: 21–58, 1981.
Jocelyn W: Biochemistry of the Thiols, New York, Academic Press, 1973.
Varnes ME, Biaglow JE: Interactions of the carcinogen 4-nitroguinoline-1-oxide with the non-protein thiols of mammalian cells. Cancer Res. 39: 3960–3965, 1979.
Tietze F: Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27: 502–522, 1969.
Harris JW: Mammalian cell studies with diamide. Pharmacol. Ther. 7: 375–391, 1979.
Vos O, Grant A, Budke L: Radiosensitization of mammalian cells by diamide. Int. J. Radiat. Biol. 6: 513–522, 1976.
Martin P, Tobias CA, Blakely EA: Differential post-irradiation sensitization by diamide under aerobic and hypoxic conditions. Radiat. Res., Abstract, 1983.
Biaglow JE, Jacobson B, Greenstock CL, Raleigh J: Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol. Pharmacol. 13: 269–282, 1977.
Biaglow JE: Cellular electron transfer and radical mechanism for drug metabolism. Radiat. Res. 86: 212–242, 1981.
Nygaard OF, Biaglow JE, Harris JW: Role of nonprotein thiols in cellular radiation response: Biochemical studies with diamide. Proceedings of Combined Modality Cancer Treatment, Cancer Management 5, Chapter 24, Brady L (ed), New York, Masson Publishing, Inc., 1980, pp. 164–171.
Biaglow JE, Nygaard OF: The use of the oxidant “diamide” for studying the non-mitochondrial reducing capacity of Ehrlich ascites tumor cells. Biochem. Biophys. Res. Commun. 54: 874–880, 1973.
Jacobson B, Biaglow JE, Fielden ME, Adams GE: Respiratory effects and ascorbate reactions with misonidazole and other recently developed drugs. Cancer Clinical Trials 3: 47–53, 1980.
Varnes ME, Biaglow JE: Mechanism of action of misonidazole: Stimulation of hexose monophosphate shunt activity. Radiat. Res. 91: 378, 1982.
Sinclair WK: N-ethylmaleimide and the cyclic response to x-rays of synchronous Chinese hamster cells. Radiat. Res. 55: 41–57, 1973.
Han A, Sinclair WK, Kimler BF: The effect of N-ethylmaleimide on the response to x-rays of synchronized HeLa cells. Radiat. Res. 65: 337–350, 1976.
Kimler BF, Sinclair WK, Elkind MM: N-ethylmaleimide sensitization of x-irradiated hypoxic Chinese hamster cells. Radiat. Res. 71: 204–213, 1977.
Biaglow JE, Varnes ME: Mechanism of action of thiol depleting agents. Submitted to Radiat. Res., 1985.
Biaglow JE, Clark E, Epp E et al: Nonprotein thiols and the radiation response of A549 human lung carcinoma cells. Int. J. Radiat. Biol. 4: 489–495, 1983.
Bump EA, Yu NY, Brown JM: The use of drugs which depletes intracellular glutathione in hypoxic cell radiosensit-ization. Int. J. Radiat. Oncol. Biol. Phys. 8: 439–442, 1982.
Mitchell JB, Russo A, Biaglow JE, McPherson S: Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine and its effects on the oxygen enhancement ratio. Radiat. Res. 94: 612–620, 1983.
Adams GE: Accomplishments, problems and prospects—A conference discussion. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 749–760.
Plummer JW, Smith BR, Sies H, Bend JR: Chemical depletion of glutathione in vivo. In: Methods of Enzymology, Jacoby WA (ed), New York, Academic Press, 1981, pp. 50–58.
Webb JL, Maleate: Enzyme and Metabolic Inhibition, Vol. I, Chapter 2, Webb JL (ed), New York, Academic Press, 1966, pp. 285–335.
Biaglow JE, Bump EA, Varnes ME: Mechanism of enhanced radiation response of misonidazole in combination with thiol removing agents. Radiat. Res., Abstract, 1985.
Biaglow JE, Varnes ME, Astor M, Hall EJ: Non-protein thiols and cellular response to drugs and radiation. Int. J. Radiat. Oncol. Biol. Phys. 8: 719–723, 1982.
Agnew DA, Skarsgard LD: Chemical radiosensitization of anoxic mammalian cells: Effect of cell concentration. Radiat. Res. 57: 246–259, 1974.
Dethmers JK, Meister A: Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc. Natl. Acad. Sci. 78: 7492–7496, 1981.
Clark EP, Epp ER, Biaglow JE: Glutathione depletion, radiosensitization and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine. Rad. Res. 98: 370–380, 1984.
Biaglow JE, Varnes ME, Astor M et al: Intracellular thiols: Involvement in drug metabolism and radiation response. In: Radioprotectors and Anticarcinogens, Nygaard OF, Simic M (eds), New York, Academic Press, 1983, pp. 203–235.
Adams GE: Radiation sensitizers for hypoxic cells. In: Treatment of Radioresistant Cancers, Abe M, Sakamoto K, Philips TL (eds), New York, Biomedical Press, 1979, pp. 3–19.
Astor M, Hall EJ, Biaglow JE: Newly synthesized hypoxia mediated drugs as radiosensitizers and cytotoxic agents. Int. J. Radiat. Oncol. Biol. Phys. 8: 75–83, 1982.
Hall EJ, Astor M, Biaglow JE, Parham JC: The enhanced sensitivity of mammalian cells to killing by x-rays after prolonged exposure to several nitroimidazoles. Int. J. Radiat. Oncol. Biol. Phys. 8: 447–451, 1982.
Stratford IJ, Hoe S, Adams GE et al: Abnormal radiosensitizing and cytotoxic properties of ortho-substituted nitroimidazoles. Int. J. Radiat. Biol. 43: 31–43, 1983.
Wardman P: The kinetics of the reaction of “anomalous” 4-nitroimidazole radiosensitizers with thiols. Int. j. Radiat. Biol. 41: 231–235, 1982.
Roizin-Towle L, Hall EJ, Flynn M et al: Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: The role of endogenous thiols. Int. J. Radiat. Oncol. Biol. Phys. 43: 757–761, 1982.
Taylor YC, Bump EA, Brown JM: Studies on the mechanism of chemosensitization by misonidazole in vitro. Int. J. Radiat. Oncol. Biol. Phys. 43: 705–708, 1982.
Wendel A: Glutathione peroxidase. In: Methods of Enzymology, Jakoby WB (ed), New York, Academic Press, 1982, pp. 325–333.
Biaglow JE, Varnes ME, Epp ER et al: Factors involved in depletion of glutathione from A549 human lung carcinoma cells: Implications for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 10: 1221–1228, 1984.
Varnes ME, Biaglow JE: Misonidazole-induced biochemical alterations of mammalian cells: Effects on glycolysis. Int. J. Radiat. Oncol. Biol. Phys. 8: 683–686, 1982.
Varnes ME, Biaglow JE, Roizin-Towle LK, Hall EJ: Depletion of glutathione and NPSH by buthionine sulfoximine and diethylmaleate: Factors that influence enhancement of aerobic radiation response. Int. J. Radiat. Oncol. Biol. Phys. 10: 1229–1234, 1984.
Olive PL: Inhibition of DNA synthesis by nitroheterocycles. I. Correlation with half-wave reduction potential. Br. J. Cancer 40: 89–93, 1979.
Varnes ME, Tuttle SW, Biaglow JE: Nitroheterocycle metabolism in mammalian cells: Stimulation of the hexose monophosphate shunt. Biochem. Pharm. 30: 1671–1677, 1984.
Biaglow JE: The effect of hypoxic cell radiosensitizing drugs on cellular oxygen utilization. Pharmacol. Reviews 10: 283–299, 1980.
Donahue L, Biaglow JE, Varnes ME: Use of peroxidase and oxidase electrodes to determine tumor cell metabolism of peroxide. Adv. Experimental Medicine, in press, 1986.
Yau TM: Mutagenicity and cytotoxicity of malondialdehyde. In: Mammalian Cells, Mechanism of Ageing and Development, Vol. 11, 1979, pp. 137–147.
Biaglow JE, Varnes ME, Epp ER, Clark EP: Redox enzymes and thiol radicals. In: Oxygen Radicals in Chemistry and Medicine, Pergamon Press, in press, 1986.
Astor M, Hall EJ, Martin J et al: Radiosensitizing and cytotoxic properties of ortho-substitute 4-and 5-nitroimidazole. Int. J. Radiat. Oncol. Biol. Phys. 8: 409–415, 1982.
Singh A, Petkau A: Singlet oxygen and related species in chemistry and biology. Photochem. Photobiol. 28: 429–921, 1977.
Younes M, Siegers CP: Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem-Biol. Interac. 34: 257–266, 1981.
Meister A: Selective modification of glutathione metabolism. Science 220: 472–477, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Biaglow, J.E., Varnes, M.E., Clark, E.P., Epp, E.R. (1986). The Role of Cellular Glutathione in Response of Tumor Cells to Radiation and Drugs. In: Valeriote, F.A., Baker, L.H. (eds) Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches. Developments in Oncology, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2331-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2331-0_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9432-0
Online ISBN: 978-1-4613-2331-0
eBook Packages: Springer Book Archive